Paul A. Romness - 21 Oct 2025 Form 4/A - Amendment Insider Report for OS Therapies Inc (OSTX)

Role
President and CEO, Director
Signature
/s/ Paul A. Romness
Issuer symbol
OSTX
Transactions as of
21 Oct 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
13 Feb 2026, 16:20:06 UTC
Date Of Original Report
19 Dec 2025
Previous filing
28 Feb 2025
Next filing
13 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Romness Paul A. President and CEO, Director C/O OS THERAPIES INCORPORATED, 115 PULLMAN CROSSING ROAD, SUITE 103, GRASONVILLE /s/ Paul A. Romness 13 Feb 2026 0001974517

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OSTX Common Stock 2,473,000 21 Oct 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSTX Stock options (right to buy) Award $0 +1,000,000 $0.000000 1,000,000 21 Oct 2025 Common Stock 1,000,000 $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 21, 2025, the reporting person was granted options to purchase 1,000,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement. These options vest in full on the one-year anniversary of the date of grant, provided that the reporting person is serving as an employee of the issuer on such date.

Remarks:

On December 19, 2025, the reporting person filed a Form 4 that incorrectly reported the number of shares of common stock underlying the stock option award grant in Table II. This amended Form 4 is being filed to correctly report in Table II the number of shares of common stock underlying the stock option award grant that occurred on October 21, 2025.